Using Evidence to Prepare Non-Oncology Nurses for Cancer Survivor Care

被引:4
|
作者
Lockhart, Joan Such [1 ]
Oberleitner, Melinda G. [4 ,5 ,6 ]
Felice, Toni L. [2 ]
Vioral, Anna [3 ]
机构
[1] Duquesne Univ, Sch Nursing, 311 Fisher Hall,600 Forbes Ave, Pittsburgh, PA 15282 USA
[2] Oncol Nursing Soc, Grants & Resources, Pittsburgh, PA USA
[3] Allegheny Hlth Network Canc Inst, Oncol Educ & Res, Pittsburgh, PA USA
[4] Univ Louisiana Lafayette, Coll Nursing & Allied Hlth Profess, Lafayette, LA 70504 USA
[5] Univ Louisiana Lafayette, Dept Nursing, Lafayette, LA 70504 USA
[6] Univ Louisiana Lafayette, Nursing, Lafayette, LA 70504 USA
来源
关键词
EDUCATION; PROGRAMS;
D O I
10.3928/00220124-20180102-05
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Background: Growing increases in current and projected cancer survivors demands a workforce that can safely meet their health care needs spanning a lifetime. The literature lacks sufficient evidence regarding the knowledge needed by non-oncology nurses who care for cancer survivors in settings not designated for cancer care. This study identified this oncology knowledge and perceived barriers. Method: The Cancer Nursing Curriculum Survey was completed by a national pool of 302 oncology and 313 medical-surgical nurses who rated the depth and importance of 33 cancer concepts needed by non-oncology nurses for cancer survivor care. Results: Concept means for depth and importance were similar between both groups, with importance rated higher. Major concepts focused on symptom management. Barriers included lack of time, knowledge, and access to resources. Conclusion: The findings indicate the understanding of knowledge needed by non-oncology nurses for survivor care and provide a first step to design continuing education to address needs.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [31] Evidence-Based Critical Care Education for Oncology Nurses
    Leake, Jennifer
    Powers, Kelly
    Rutledge, Sarah
    [J]. DIMENSIONS OF CRITICAL CARE NURSING, 2022, 41 (04) : 171 - 177
  • [32] THE ROLE OF NON-ONCOLOGY SPECIALTIES IN THE REAL WORLD LONGITUDINAL JOURNEY OF PROSTATE CANCER PATIENTS
    ARgentinis, E.
    Mazumder, D.
    Singh, D.
    [J]. VALUE IN HEALTH, 2020, 23 : S83 - S83
  • [33] Breaking bad news: A training program for non-oncology physicians using the spikes protocol
    Anfossi, M.
    Numico, G.
    Dardanelli, L.
    Cento, G.
    [J]. PSYCHO-ONCOLOGY, 2006, 15 (02) : S159 - S159
  • [34] The role of non-oncology specialties in the real world longitudinal journey of prostate cancer patients.
    Carnegie, Daniel
    Argentinis, Elenee
    Mazumder, Dibyajyoti
    Dhangar, Indu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] POPULATION EVIDENCE TO SUPPORT A MODEL OF CHILD CANCER SURVIVOR CARE
    McBride, M. L.
    Goddard, K.
    Pritchard, S.
    Fryer, C.
    Walks, F.
    Byron, P.
    Blain, K.
    Rogers, P.
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : S174 - S175
  • [36] WHERE TO CARE FOR CHILDHOOD CANCER SURVIVORS? SURVIVOR AND ONCOLOGY SERVICE PROVIDER PERSPECTIVES
    McLoone, Jordana K.
    Wakefield, Claire E.
    Lawrence, Renae
    Cohn, Richard J.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 124 - 124
  • [37] Developing and Using Online Courses to Prepare Nurses for Employment in Critical Care
    Billings, Diane M.
    Jeffries, Pamela R.
    Daniels, Dawn Marie
    Rowles, Connie
    Stone, Cynthia L.
    Stephenson, Evelyn
    [J]. JOURNAL FOR NURSES IN PROFESSIONAL DEVELOPMENT, 2006, 22 (02) : 87 - 92
  • [38] EVIDENCE-BASED PRACTICE IN CANCER CARE: OPPORTUNITIES AND RESULTS FROM A NATIONAL SURVEY OF ONCOLOGY NURSES
    Ginex, Pamela
    Dickman, Erin
    Thomas, Bindu
    Tucker, Sharon
    Guo, Jinhong
    Gallagher-Ford, Lynn
    [J]. ONCOLOGY NURSING FORUM, 2020, 47 (02)
  • [39] Repurposing non-oncology drugs with MET inhibitory effect to overcome osimertinib resistance in lung cancer
    To, Kenneth K. W.
    Leung, Kwong Sak
    Cho, William C. S.
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [40] The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.
    Waissengrin, Barliz
    Wolf, Ido
    Zahavi, Tamar
    Salmon-Divon, Mali
    Sonnenblick, Amir
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)